{"active_ingredient":["DESCRIPTION: 150 Capsules are a highly water soluble complex of iron and a low molecular weight polysaccharide."],"boxed_warning":["WARNING Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep these products out of the reach of children. In case of accidental overdose, call a doctor or poison control center immediately."],"contraindications":["CONTRAINDICATIONS: In patients with hemochromatosis and hemosiderosis and in those with known hypersensitivity to any of the ingredients. Adverse Reactions: Adverse reactions with iron therapy may include constipation, diarrhea, nausea, vomiting, dark stools, and abdominal pain. Adverse reactions with iron therapy are usually transient."],"dosage_and_administration":["DOSAGE AND ADMINISTRATION: Adults - 1 to 2 capsules daily; pediatric patients, as directed by a physician."],"effective_time":"20130121","how_supplied":["HOW SUPPLIED: IFEREX™ 150 Capsules are brown cap/opaque orange body imprinted “ZIKS” (Cap)/”0203” (body), Bottles of 100 - NDC 54868-5012-0 Each capsule contains: Iron (Elemental) . . . . . . . . . . . . . . . . . . . . . . . . . 150 mg (as polysaccharide-iron complex)"],"id":"8bd3b531-f505-4f80-a264-1bebf6072ba9","inactive_ingredient":["INACTIVE INGREDIENTS: Black Iron oxide,FD&C Red #28, FD&C Yellow # 10, FD&C blue #1, FD&C red #40, FD&C yellow #6, gelatin, magnesium stearate, microcrystalline cellulose,Red Iron Oxide, and Titanium Dioxide KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN. IN CASE OF ACCIDENTAL OVERDOSE, SEEK PROFESSIONAL ASSISTANCE OR CONTACT A POISON CONTROL CENTER IMMEDIATELY. Storage: Store at controlled room temperature 15°-30°C (59°-86°F). Manufactured for Nnodum Pharmaceutical Cincinnati, Ohio 45229 Additional barcode labeling by: Physicians Total Care, Inc. Tulsa, Oklahoma 74146"],"indications_and_usage":["INDICATIONS: Iferex 150 is indicated for the prevention and treatment of iron deficiency anemia and / or nutritional megalobastic anemias."],"keep_out_of_reach_of_children":["Enter section text here"],"openfda":{},"package_label_principal_display_panel":["PACKAGE LABEL.PRINCIPAL DISPLAY PANEL image of package label"],"purpose":["ACTIONS AND USES: an easily assimilated source of iron for treatment of uncomplicated iron deficiency anemia. Because IFEREX™ 150 is a polysaccharide bound iron complex, it is relatively nontoxic and there are relatively few, if any, gastrointestinal side effects associated with iron therapy, thus permitting full therapeutic dosage (150 - 300 mg elemental iron daily) in a single dose if desirable. There is no staining of teeth and no metallic aftertaste."],"set_id":"2b5cf8e3-c45d-4c61-b36c-948b2330f22c","spl_product_data_elements":["Polysacc Iron Complex Polysaccharide-Iron Complex IRON IRON FERROSOFERRIC OXIDE FD&C BLUE NO. 1 FD&C RED NO. 40 FD&C YELLOW NO. 6 GELATIN MAGNESIUM STEARATE CELLULOSE, MICROCRYSTALLINE FERRIC OXIDE RED TITANIUM DIOXIDE opaque orange body brown cap ZIKS;0203"],"spl_unclassified_section":["(Polysaccharide-Iron Complex) Hematinic NDC 54868-5012-0"],"version":"2","warnings":["WARNINGS: Keep out of reach of children. Contains iron, which can be harmful or fatal to children in large doses. Pediatric Use: Safety and effectiveness in pediatric patients has not been established. Geriatric Use: Clinical studies on this product have not been performed in sufficient numbers of subjects aged 65 and over to determine whether elderly subjects respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal or cardiac function, and of concomitant disease or other drug therapy."]}